Fisetin in Mild Alzheimer's Disease

Recruiting now · Phase 2

Conditions studied: Alzheimer s Disease, Alzheimer Dementia, Alzheimer Dementia (AD), Alzheimer Disease, Mild Cognitive Disorder, Neurocognitive Disorders, Mild, Neurocognitive Disorder

In brief

This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.

Key facts

Study ID
NCT07279714
Run by
Sunnybrook Health Sciences Centre
People needed
5
Starts
2026-01-27
Expected to finish
2026-11-01
Last updated by the study team
2026-04-13

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.